Properties |
Information |
PhytoCAT-ID |
PhytoCAT-713 |
Phytochemical name or plant extracts |
Rumex vesicarius extract |
PMID |
32210679 |
Literature evidence |
As the phytochemicals and botanical crude extracts have proven their efficacy as natural antiangiogenic agents with minimum toxicities, there is need to explore varieties of medicinal plants for novel antiangiogenic compounds. |
IUPAC name |
NA |
Phytochemicals’ class or type of plant extracts |
Methanol, Chloroform, ethyl acetate and n-hexane extract |
Source of phytochemicals or plant Extracts |
Rumex vesicarius |
|
Geographical availability |
Afghanistan, Algeria, Assam, Bangladesh, Canary Is., Cape Verde, Chad, Djibouti, Egypt, Eritrea, Gulf States, India, Iran, Iraq, Kuwait, Lebanon-Syria, Libya, Mauritania, Morocco, Myanmar, Niger, Oman, Pakistan, Palestine, Saudi Arabia, Sinai, Somalia, Sudan, Tunisia, West Himalaya, Western Sahara, Yemen |
Plant parts |
Root, Stem, Leaves and Flowers |
Other cancers |
Breast cancer, Colon carcinoma, Hepatocellular carcinoma |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
NA |
IC50 |
Chloroform extract of stem - 33.45 ± 0.24 µM against MCF-7
Ethyl acetate extract of stem - 64.26 ± 0.33 µM against MCF-7
The IC50 values of the crude extracts prepared from the roots, and leaves were above than 500 µM. |
Potency |
R. vesicarius can further be tested in clinical trials in order to explore its therapeutic potential as an effective and safe natural anticancer product. |
Cell line/ mice model |
MCF-7, HepG2, Lovo, Caco-2 |
Additional information |
Moreover, the crude extract prepared from other plants parts such as roots, leaves and flowers of R.
vesicarius were completely in active in term of antiangiogenic activity in transgenic zebrafish embryos. |
PubChem ID |
NA |
Additional PMIDs |
NA |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:697616-1 |
Safety |
NA |